MiNK Therapeutics, Inc. (INKT) Operating income 2020–2025
MiNK Therapeutics, Inc. (INKT) annual operating income history from SEC filings — each fiscal year as reported.
-$12.6MFY2025 · since FY2020: -$14.6M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -12.0% |
| FY2024 | -$11.3M | +50.8% |
| FY2023 | -$22.9M | +25.9% |
| FY2022 | -$30.9M | -9.1% |
| FY2021 | -$28.4M | -93.7% |
| FY2020 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice